Emergency Contraception (ECP): Reducing Unintended Pregnancies
NCT00067509 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1100
Last updated 2005-06-24
Summary
Emergency contraception is a method of birth control that can be used up to three days after sexual intercourse. Emergency contraceptive pills (ECPs) can be given to a woman before she needs them (advance provision) or when she needs them (emergency provision). This study will compare these two methods of providing ECPs.
Conditions
- Contraception
- Pregnancy
Interventions
- DRUG
-
emergency contraception (estrogen/progesterone)
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Principal Investigators
-
Paul G Whittaker, D.Phil.
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 15 Years
- Max Age
- 39 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-06-30
- Completion
- 2004-05-31
Countries
- United States
Study Locations
More Related Trials
-
Emergency Contraception and Body Weight: Pilot Study
NCT02408692 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg
NCT03537768 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy of CDB-2914 for Emergency Contraception
NCT00411684 ·Status: COMPLETED ·Phase: PHASE3
-
Depot Medroxyprogesterone Acetate as Emergency Contraception
NCT03395756 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Contraception Initiation Feasibility in the Pediatric ED
NCT03559634 ·Status: COMPLETED ·Phase: NA
-
Disparities in Emergency Contraceptive Metabolism Dictate Efficacy
NCT05674513 ·Status: RECRUITING ·Phase: PHASE4
-
Drospirenone-only Pill as Emergency Contraception
NCT05675644 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy Trial of CDB 2914 for Emergency Contraception
NCT00271583 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive
NCT03296098 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days
NCT01953679 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
NCT00253019 ·Status: COMPLETED
-
Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"
NCT04676776 ·Status: UNKNOWN ·Phase: PHASE2
-
Impact of Combined Hormonal Contraceptives on UPA
NCT02577601 ·Status: COMPLETED ·Phase: PHASE4
-
Contraceptive Choice at the Time of Uterine Evacuation
NCT02836561 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception
NCT02173808 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
NCT04143659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring
NCT00455156 ·Status: COMPLETED ·Phase: PHASE3
-
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
NCT00966771 ·Status: COMPLETED
-
Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
NCT00551616 ·Status: COMPLETED ·Phase: PHASE3
-
Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant
NCT04074174 ·Status: COMPLETED ·Phase: PHASE1
-
Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients
NCT05505435 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
NCT00245921 ·Status: COMPLETED ·Phase: PHASE3
-
Awareness & Use of Emergency Contraception
NCT04172584 ·Status: UNKNOWN
-
Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women
NCT01107106 ·Status: COMPLETED
-
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
NCT00236769 ·Status: COMPLETED ·Phase: PHASE3